| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |